These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15803093)

  • 21. [Paediatric oncology in Hungary].
    Schuler D
    Orv Hetil; 2012 May; 153(21):803-10. PubMed ID: 22617369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Association of Cancer Research--95th annual meeting. Highlights. 27-31 March, 2004, Orlando, FL, USA.
    Kibble A; Davies J
    IDrugs; 2004 May; 7(5):416-9. PubMed ID: 15154096
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy Foundation Symposium XII. Innovative Cancer Chemotherapy for Tomorrow. New York City, November 9-11, 1994. Abstracts.
    Cancer Invest; 1995; 13 Suppl 1():1-59. PubMed ID: 7614145
    [No Abstract]   [Full Text] [Related]  

  • 24. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
    Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
    Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
    [No Abstract]   [Full Text] [Related]  

  • 25. Oncology. Are Voltaire and Rousseau now wrong?
    Raghavan D
    Lancet; 1996 Dec 21-28; 348 Suppl 2():sII17. PubMed ID: 8973495
    [No Abstract]   [Full Text] [Related]  

  • 26. New Agents in Clinical Oncology. 24 November 2006, London, UK.
    Martin S
    IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
    [No Abstract]   [Full Text] [Related]  

  • 27. Personalized cancer therapy gets closer.
    Hayden EC
    Nature; 2009 Mar; 458(7235):131-2. PubMed ID: 19279593
    [No Abstract]   [Full Text] [Related]  

  • 28. ESMO 2014: new trends in precision medicine.
    Morere JF; Innominato P
    Target Oncol; 2014 Dec; 9(4):293-4. PubMed ID: 25503266
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current trends in clinical chemotherapy of tumors].
    Garan AM
    Vopr Onkol; 1983; 29(1):93-8. PubMed ID: 6823764
    [No Abstract]   [Full Text] [Related]  

  • 30. 25 years of oncology.
    Spittle MF
    Br J Hosp Med; 1991 Oct; 46(4):249, 251. PubMed ID: 1954491
    [No Abstract]   [Full Text] [Related]  

  • 31. X chemotherapy, myth and realities.
    Thomas M; Pavithran K
    J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Great risk of future problems for Swedish cancer care].
    Bergh J; Wilking N
    Lakartidningen; 2010 Oct 6-12; 107(40):2376-7. PubMed ID: 21140568
    [No Abstract]   [Full Text] [Related]  

  • 33. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologists have lost a battle against cancer; biomedicine has not lost the war.
    Mathé G
    Biomed Pharmacother; 1986; 40(10):370-1. PubMed ID: 3580504
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy Foundation Symposium XV. Innovative Cancer Therapy for Tomorrow. New York City, New York, USA. November 12-14, 1997. Abstracts.
    Cancer Invest; 1998; 16 Suppl 1():1-85. PubMed ID: 9533009
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer research in the United States: A critical review of current status and proposal for alternative models.
    Kantarjian HM; Prat F; Steensma DP; Kurzrock R; Stewart DJ; Sekeres MA; Leveque J
    Cancer; 2018 Jul; 124(14):2881-2889. PubMed ID: 29757456
    [No Abstract]   [Full Text] [Related]  

  • 37. 'Flat-fixed dosing' of chemotherapy: a concept whose time has come?
    Markman M
    Curr Oncol Rep; 2005 Jan; 7(1):1-2. PubMed ID: 15610676
    [No Abstract]   [Full Text] [Related]  

  • 38. Selected new developments in oncology.
    Beijnen JH; Schellens JH
    Curr Clin Pharmacol; 2010 Aug; 5(3):140. PubMed ID: 20450478
    [No Abstract]   [Full Text] [Related]  

  • 39. [Development of geriatric oncology within the framework of the cancer plan].
    Rodde Dunet MH; Vitoux A
    Med Sci (Paris); 2007 Oct; 23 Spec No 3():47-51. PubMed ID: 17939929
    [No Abstract]   [Full Text] [Related]  

  • 40. 20th-century advances in drug therapy in oncology--Part I.
    Dutcher JP; Novik Y; O'Boyle K; Marcoullis G; Secco C; Wiernik PH
    J Clin Pharmacol; 2000 Sep; 40(9):1007-24. PubMed ID: 10975071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.